Nov 7 (Reuters)- Cosmo Bio Co Ltd CONSOLIDATED FINANCIAL HIGHLIGHTS (in billions of yen unless specified) 9 months ended 9 months ended Year to Sep 30, 2025 Sep 30, 2024 Dec 31, 2025 LATEST YEAR-AGO LATEST RESULTS RESULTS FORECAST Sales 7.89 7.41 10.70 (+6.4 pct) (+7.7 pct) (+6.6 pct) Operating 275 mln 369 mln 490 mln (-25.4 pct) (-17.5 pct) (+53.8 pct) Recurring 369 mln 384 mln 580 mln (-3.9 pct) (-30.6 pct) (+59.2 pct) Net 272 mln 291 mln 430 mln (-6.3 pct) (-20.4 pct) (+64.1 pct) EPS 47.96 yen 49.92 yen 75.77 yen Ann Div 50.00 yen 50.00 yen -Q2 div 25.00 yen 14.00 yen -Q4 div 36.00 yen 25.00 yen NOTE - Cosmo Bio Co Ltd. To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3386.T